Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: Implications for adjuvant radiotherapy

BJU International

Volumn 105, Issue 10, 2010, Pages 1377-1380

  Resnick, Matthew J ^a   Canter, Daniel J ^a   Guzzo, Thomas J ^a   Magerfleisch, Laurie ^a   Tomaszewski, John E ^b   Brucker, Benjamin M ^a   Bergey, Meredith R ^a   Sonnad, Seema S ^a   Wein, Alan J ^a   Malkowicz, S Bruce ^a  

^a School of Veterinary Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adjuvant radiotherapy; Positive margin; Prostate neoplasia; Risk stratification; Tumour volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; DATA BASE; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; POSITIVE SURGICAL MARGIN; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77951713756     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08953.x     Document Type: Article

References (20)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005 55 : 10 30
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998 48 : 6 29
3. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term Results. J Urol 2004 172 : 910 914
4. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001 28 : 555 565
5. Swindle P, Eastham JA, Ohori M et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 2005 174 : 903 907
6. Pettus JA, Weight CJ, Thompson CJ, Middleton RG, Stephenson RA. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J Urol 2004 172 : 129 132
7. Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001 165 : 119 125
8. Kausik SJ, Blute ML, Sebo TJ et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer 2002 95 : 1215 1219
9. Guzzo TJ, Vira MA, Neway W et al. Minimal tumor Volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology 2007 69 : 1147 1151
10. Obek C, Sadek S, Lai S, Civantos F, Rubinowicz D, Soloway MS. Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology 1999 54 : 682 688
11. Jayachandran J, Banez LL, Levy DE et al. Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: Results from the SEARCH database. J Urol 2008 179 : 1791 1796
12. Epstein JI. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am 1996 23 : 651 663
13. Han M, Partin AW, Chan DY, Walsh PC. An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. J Urol 2004 171 : 23 6
14. Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int 2008 102 : 1413 1418
15. Stephenson AJ, Shariat SF, Zelefsky MJ et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004 291 : 1325 1332
16. Van der Kwast TH, Bolla M, Van Poppel H et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007 25 : 4178 4186
17. Karakiewicz PI, Eastham JA, Graefen M et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 2005 66 : 1245 1250
18. Thompson IM Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006 296 : 2329 2335
19. Thompson IM, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009 181 : 956 962
20. Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005 366 : 572 578